214 related articles for article (PubMed ID: 7681206)
1. Measurement of cellular proliferation in human prostate by AgNOR, PCNA, and SPF.
Sakr WA; Sarkar FH; Sreepathi P; Drozdowicz S; Crissman JD
Prostate; 1993; 22(2):147-54. PubMed ID: 7681206
[TBL] [Abstract][Full Text] [Related]
2. Nucleolar organizer regions and PCNA expression in prostatic cancers.
Kawase N; Shiokawa A; Ota H; Saitoh T; Yoshida H; Kazama K
Pathol Int; 1994 Mar; 44(3):213-22. PubMed ID: 7517763
[TBL] [Abstract][Full Text] [Related]
3. Assessment of proliferative activity by AgNOR and PCNA in prostatic tissues of ram lambs implanted with zeranol.
Gulbahar MY; Yuksel H; Guvenc T; Okut H
Reprod Domest Anim; 2005 Oct; 40(5):468-74. PubMed ID: 16149954
[TBL] [Abstract][Full Text] [Related]
4. Proliferative activity in the malignant cellular blue nevus.
Pich A; Chiusa L; Margaria E; Aloi F
Hum Pathol; 1993 Dec; 24(12):1323-9. PubMed ID: 7903955
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
[TBL] [Abstract][Full Text] [Related]
6. Nucleolar organizer regions (NORs) staining and proliferating cell nuclear antigen (PCNA) immunostaining in mucosa-associated lymphoid tissue (MALT) gastric lymphomas.
Mikou P; Kanavaros P; Aninos D; Tzardi M; Karameris A; Gorgoulis B; Papadopoulos N; Lavergne A; Galian A
Pathol Res Pract; 1993 Nov; 189(9):1004-9. PubMed ID: 7905623
[TBL] [Abstract][Full Text] [Related]
7. High and low risk prostate carcinoma determined by histologic grade and proliferative activity.
Chiusa L; Galliano D; Formiconi A; Di Primio O; Pich A
Cancer; 1997 May; 79(10):1956-63. PubMed ID: 9149023
[TBL] [Abstract][Full Text] [Related]
8. AgNOR staining in benign hyperplasia and carcinoma of the prostate.
Mamaeva S; Lundgren R; Elfving P; Limon J; Mandahl N; Mamaev N; Henrikson H; Heim S; Mitelman F
Prostate; 1991; 18(2):155-62. PubMed ID: 1706512
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.
Ghazizadeh M; Sasaki Y; Araki T; Konishi H; Aihara K
Am J Clin Pathol; 1997 Apr; 107(4):451-8. PubMed ID: 9124214
[TBL] [Abstract][Full Text] [Related]
10. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between the nucleolar organizer region in adenocarcinoma of the prostate and the Gleason system].
Sentinelli S; Pizzuti V; Rondanelli E; Viggiani F; Paolini R
Pathologica; 1992; 84(1089):49-55. PubMed ID: 1379709
[TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections.
Korkolopoulou P; Christodoulou P; Papanikolaou A; Thomas-Tsagli E
Am J Surg Pathol; 1993 Sep; 17(9):912-9. PubMed ID: 8102513
[TBL] [Abstract][Full Text] [Related]
13. Proliferative activity is a significant prognostic factor in male breast carcinoma.
Pich A; Margaria E; Chiusa L
Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
[TBL] [Abstract][Full Text] [Related]
14. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours.
Yu CC; Fletcher CD; Newman PL; Goodlad JR; Burton JC; Levison DA
J Pathol; 1992 Feb; 166(2):147-52. PubMed ID: 1348532
[TBL] [Abstract][Full Text] [Related]
15. DNA index, cellular proliferative activity and nucleolar organizer regions in cancers of the larynx.
Cappiello J; Nicolai P; Antonelli AR; Facchetti F; Cadei M; Cornacchiari A; Grigolato PG
Eur Arch Otorhinolaryngol; 1995; 252(6):353-8. PubMed ID: 8679155
[TBL] [Abstract][Full Text] [Related]
16. The AgNOR technique, PCNA immunohistochemistry, and DNA ploidy in the evaluation of choroid plexus biopsy specimens.
Centeno BA; Louis DN; Kupsky WJ; Preffer FI; Sobel RA
Am J Clin Pathol; 1993 Dec; 100(6):690-6. PubMed ID: 7902669
[TBL] [Abstract][Full Text] [Related]
17. Silver staining nucleolar organizer region in prostate cytology.
Bittinger A; von Keitz A; Rüschoff J; Melekos MD
Zentralbl Pathol; 1994 Mar; 140(1):103-6. PubMed ID: 7515666
[TBL] [Abstract][Full Text] [Related]
18. Argyrophilic nucleolar organizer regions in breast carcinoma. Correlation with DNA flow cytometry, histopathology, and lymph node status.
Mourad WA; Erkman-Balis B; Livingston S; Shoukri M; Cox CE; Nicosia SV; Rowlands DT
Cancer; 1992 Apr; 69(7):1739-44. PubMed ID: 1312892
[TBL] [Abstract][Full Text] [Related]
19. Nucleolar organiser regions in hyperplastic and neoplastic prostatic tissue.
Hansen AB; Ostergård B
Virchows Arch A Pathol Anat Histopathol; 1990; 417(1):9-13. PubMed ID: 1694333
[TBL] [Abstract][Full Text] [Related]
20. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
